
Ulterfast 37.5mg/325mg Tablet
Marketer
Matias Healthcare Pvt Ltd
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Ulterfast 37.5mg/325mg Tablet
RapidRelief 37.5mg/325mg tablets combine two analgesics to effectively manage moderate to severe pain. Adhere strictly to your physician's prescribed dosage and regimen. Consumption may coincide with or precede meals; if stomach discomfort occurs, take with food. Consistent medication is crucial; discontinue only under your doctor's guidance. Potential side effects include nausea, vomiting, dry mouth, dizziness, and constipation—typically mild and transient. Report any rash or allergic reaction promptly. Pregnant individuals, those planning pregnancy, or breastfeeding mothers should consult their physician before commencing treatment.
Uses of Ulterfast 37.5mg/325mg Tablet
Significant to intense discomfort
Major Benefits of Ulterfast 37.5mg/325mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ulterfast 37.5mg/325mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Ulterfast 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Ulterfast 37.5mg/325mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; do not break, crush, or chew it. Ulterfast 37.5mg/325mg tablets can be consumed with or without food, though consistent timing is recommended.
How Ulterfast 37.5mg/325mg Tablet works:
Each Ulterfast 37.5mg/325mg tablet combines tramadol and paracetamol to effectively manage intense pain. Tramadol, an opioid analgesic, diminishes pain sensation by interrupting pain signals to the brain. Paracetamol acts by inhibiting the production of pain-inducing chemical mediators.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ulterfast 37.5mg/325mg tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Ulterfast 37.5mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice from your doctor.
Breast feedingSAFE IF PRESCRIBED
Taking Ulterfast 37.5mg/325mg tablets while breastfeeding is likely safe. Available human data indicates minimal infant risk. However, seek immediate medical attention if your baby exhibits excessive sleepiness, feeding difficulties, respiratory issues, or unusual lethargy.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Ulterfast 37.5mg/325mg Tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Ulterfast 37.5mg/325mg tablets. Dosage modification of Ulterfast 37.5mg/325mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Ulterfast 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Ulterfast 37.5mg/325mg tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Ulterfast 37.5mg/325mg Tablet :
Should you forget to take your Ulterfast 37.5mg/325mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ulterfast 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
